PDIAX
Price
$21.98
Change
-$0.15 (-0.68%)
Updated
Nov 13 closing price
Net Assets
167.4M
VIVAX
Price
$73.17
Change
-$0.74 (-1.00%)
Updated
Nov 13 closing price
Net Assets
207.95B
Interact to see
Advertisement

PDIAX vs VIVAX

Header iconPDIAX vs VIVAX Comparison
Open Charts PDIAX vs VIVAXBanner chart's image
Virtus KAR Equity Income A
Price$21.98
Change-$0.15 (-0.68%)
VolumeN/A
Net Assets167.4M
Vanguard Value Index I
Price$73.17
Change-$0.74 (-1.00%)
VolumeN/A
Net Assets207.95B
PDIAX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
PDIAX vs. VIVAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDIAX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. PDIAX (167M). PDIAX pays higher dividends than VIVAX: PDIAX (3.92) vs VIVAX (1.98). PDIAX was incepted earlier than VIVAX: PDIAX (28 years) vs VIVAX (33 years). PDIAX (1.37) is less costly to investors than VIVAX (0.17). PDIAX is a more actively managed with annual turnover of: 17.00 vs. VIVAX (9.00). PDIAX has a lower initial minimum investment than VIVAX: PDIAX (0) vs VIVAX (3000). PDIAX (6.75) and VIVAX (6.68) have marching annual gain over last year. VIVAX return over 5 years is better than : 66.34 vs. PDIAX (0.97).
PDIAXVIVAXPDIAX / VIVAX
Total Expense Ratio1.200.17706%
Annual Report Gross Expense Ratio1.370.17806%
Fund Existence28 years33 years-
Gain YTD10.65811.96589%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets167M208B0%
Annual Yield % from dividends3.921.98198%
Returns for 1 year6.756.68101%
Returns for 3 years19.9833.4960%
Returns for 5 years0.9766.341%
Returns for 10 years47.58135.0035%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POAGX56.140.41
+0.74%
PRIMECAP Odyssey Aggressive Growth
LMOFX48.440.26
+0.54%
Patient Opportunity FI
NUGAX37.840.15
+0.40%
Nuveen Global Dividend Growth A
VNVAX25.890.06
+0.23%
Natixis Vaughan Nelson Mid Cap A
IHSRX24.64-0.11
-0.44%
Hartford Small Company R3